Pneumokok vaccine 20-valent
Prevnar 20
Target group:
People aged 6 weeks and older who are at increased risk of frequent or severe pneumococcal infections.
Vaccination dose:
Prevnar 20 should be administered as a single dose to people aged 2 years and older.
Protection duration:
The need for revaccination with a subsequent dose of Prevenar 20 has not been established.